Events

Apollo Therapeutics is pleased to share that Kay Penicud, VP and Head of Research Partnerships, will be speaking at the Saïd Business School, Oxford, UK on Friday, February 6th at the BHF Oxford CRE Cardiovascular Innovation Awards Kick-off Event.

At Apollo Therapeutics, we focus on bridging cutting-edge academic research with industry-leading drug discovery and development to deliver transformative medicines. Kay will discuss how industry partnerships can accelerate the commercialisation of academic research towards clinical impact.